Latest Asx News

Page 12 of 2814
Vault Minerals’ merger with Genesis Minerals has cleared its final legal hurdle and is now legally effective, setting the transaction on course for implementation next week. Vault shares are expected to stop trading after 17 November, while the final consideration mix and any scaleback remain unresolved.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Aspermont has told ASX that directors John Stark and Graeme McCracken failed to obtain prior approval or notify the company of transactions, leading to late Appendix 3Y notices. ASX raised possible listing rule and Corporations Act breaches, although no penalty or formal finding has been disclosed.
Victor Sage
Victor Sage
17 Nov 2026
Orezone Gold delivered record third-quarter production of 59,674 ounces, with revenue of US$238.5 million and operating cash flow of US$71.1 million. The ASX-listed miner also cleared its Bomboré Phase I debt and completed the Stage 2A hard-rock expansion while maintaining 2026 production guidance.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Vitrafy says it has moved from cryopreservation research into commercial execution, with 19 Guardion devices built, new US partnerships and $38.3 million in cash and term deposits. The next test is converting partner evaluations into recurring revenue after a planned FDA Class II listing in the coming weeks.
Victor Sage
Victor Sage
17 Nov 2026
Finbar has completed the $7.5 million acquisition of a 5,317-square-metre Ascot site, where it is targeting more than 200 apartments and 500 square metres of commercial space. The proposed project carries an estimated end value of $166 million, but its final yield, design and approvals are still to be determined.
Victor Sage
Victor Sage
17 Nov 2026
GTN has reaffirmed its FY27 earnings targets after a cost reset lifted operating cash flow by 69% and cut annual capital expenditure below $1 million. The company plans to distribute 100% of FY27 NPATA, although weaker revenue and a soft first quarter keep the recovery dependent on execution.
Elise Vega
Elise Vega
17 Nov 2026
Corazon Mining is evaluating a build-own-operate carbon-in-leach plant at its Chalice Gold Project, with an initial 600,000-tonne annual capacity and expansion potential to 1.8 million tonnes. The proposal could reduce upfront processing capital, but remains non-binding and depends on metallurgy, approvals, funding and a definitive contract.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Sandon Capital Investments is promoting a 7.8% fully franked dividend yield and a 7.2% discount to pre-tax NTA, while acknowledging that QPM Energy’s administration cost its portfolio about 7%. The listed investment company says its long-term record and activist holdings continue to offer value, but recent performance has lagged key benchmarks.
Claire Turing
Claire Turing
17 Nov 2026
HighCom Armor has delivered the first batch of rifle-rated combat helmets to the Pakistan Army under a US$1.6 million procurement program. Further deliveries are expected in FY27, but remain subject to final in-field acceptance.
Victor Sage
Victor Sage
17 Nov 2026
Urbanise has entered FY27 with stronger revenue, a near break-even adjusted EBITDA result and a live NAB banking pilot, but the next phase depends on turning contracted work and new platform features into recurring revenue and cash flow. The corrected AGM materials set a target for a positive operating cash flow run rate in the first half of FY28.
Sophie Babbage
Sophie Babbage
17 Nov 2026
Actinogen Medical’s shares have been suspended while it completes analysis of additional data from its pivotal XanaMIA Alzheimer’s trial. The company expects trading to resume no later than 19 November unless the results announcement comes first.
Ada Torres
Ada Torres
17 Nov 2026
Island Pharmaceuticals is moving Galidesivir into a decisive sequence of Marburg animal studies after the FDA confirmed an Animal Rule pathway for the antiviral. The company also expects to generate prospective human data through an approved Uganda Ebola program, although approval, funding and commercial outcomes remain unresolved.
Victor Sage
Victor Sage
17 Nov 2026

Browse the archive

Full archive